Shareholding2 Jun 2026, 10:52 am
Novelix Pharmaceuticals Promoters Convert Warrants into 9.5 Lakh Shares
AI Summary
Novelix Pharmaceuticals Ltd has announced the allotment of 9,50,000 equity shares to its promoters following the conversion of warrants. Srinidhi Fine-Chemicals LLP was allotted 8,00,000 shares, while Narahari Belide received 1,50,000 shares. This preferential allotment, executed on May 29, 2026, increases the company's total equity share capital to 23,895,000 shares.
Key Highlights
- Promoters converted warrants into 9,50,000 equity shares via preferential allotment.
- Srinidhi Fine-Chemicals LLP received 8,00,000 shares and Narahari Belide received 1,50,000 shares.
- Post-allotment, the company's total equity share capital increased to 23,895,000 shares.
- The disclosure was made in compliance with SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.
Price Impact
More from TRIMURTHI